Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Operating Expenses (2016 - 2025)

Organogenesis Holdings (ORGO) has 7 years of Other Operating Expenses data on record, last reported at $51.9 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 195.44% year-over-year to $51.9 million; the TTM value through Dec 2025 reached $148.7 million, up 164.92%, while the annual FY2025 figure was $148.7 million, 164.92% up from the prior year.
  • Other Operating Expenses reached $51.9 million in Q4 2025 per ORGO's latest filing, down from $146.8 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $146.8 million in Q3 2025 and bottomed at -$111.8 million in Q3 2024.
  • Average Other Operating Expenses over 3 years is $3.3 million, with a median of -$23.9 million recorded in 2024.
  • Peak YoY movement for Other Operating Expenses: tumbled 151.03% in 2024, then skyrocketed 231.37% in 2025.
  • A 3-year view of Other Operating Expenses shows it stood at $106.5 million in 2023, then crashed by 151.03% to -$54.3 million in 2024, then skyrocketed by 195.44% to $51.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $51.9 million in Q4 2025, $146.8 million in Q3 2025, and -$56.6 million in Q2 2025.